BioinformaticsbioRxivPreprint
CRISPR-enhanced assessment of variants of unknown significance nominates oncology therapeutic targets and drug repositioning opportunities
Aurora Savino, Athanasios Oikonomou, Francesca Perrone…·Francesco Iorio
CRISPR-VUS identifies rare variants linked to gene dependency in cancer cell lines, prioritizing potential drivers and therapeutic targets through functional validation.
DOI 10.64898/2026.01.20.700565